Clifford G. Robinson

Washington University in St. Louis

Papers

1

Total Citations

16

H-Index

1

About

Clifford G. Robinson is a leading radiation oncologist whose research focuses on the intersection of stereotactic body radiotherapy (SBRT) and thoracic malignancies, with a particular emphasis on lung cancer. His most-cited work, "Cancer of the Lung" (2014), has garnered 16 citations and serves as a foundational reference for clinicians and researchers navigating the complexities of lung cancer management. Robinson’s major contributions lie in advancing SBRT as a precise, non-invasive treatment for early-stage lung tumors, as well as investigating its role in oligometastatic disease—where limited metastatic spread may be aggressively targeted to improve outcomes. His clinical trials and translational studies have helped define optimal dosing, fractionation, and patient selection criteria, directly influencing practice guidelines. Beyond his published work, Robinson is recognized for his leadership in cooperative group trials and his commitment to integrating novel imaging and biomarker strategies into radiotherapy planning. With a citation impact that reflects his influence in thoracic oncology, he continues to shape how radiation is delivered to improve survival and quality of life for patients with lung cancer.

Research Focus

Key Achievements

1
H-Index
1
Papers
16
Total Citations
16
Avg Citations/Paper
🏆 Most Cited Paper
Cancer of the Lung
16 citations · 2014
📈 Most Prolific Year: 2014 (1 Papers)
🤝 Key Collaborators: 7
🏛 Institutions: Washington University in St. Louis

Top Papers

  1. 1
    Cancer of the Lung
    16 citations · 2014

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago